Allogeneic stem cell transplantation
Endoscopic Examination for Patients with Diarrhea after Allogeneic Stem Cell Transplantation
... Objective: Intestinal graft-versus-host disease (GVHD) represents one of the most serious complications of allogeneic stem cell transplantation (allo-SCT). Endoscopic and histological proof is ...
10
Biosimilar G-CSF Based Mobilization of Peripheral Blood Hematopoietic Stem Cells for Autologous and Allogeneic Stem Cell Transplantation
... for stem cell mo- bilization and may help to dispel some of the concerns appropriately raised regarding their use in this clini- cal setting,[4-8] especially in healthy related donors and unrelated ...
10
Fusarium Infection after Allogeneic Stem Cell Transplantation with Prolonged Neutropenia
... Fusarium is an opportunistic fungal pathogen which is emerging as a significant cause of morbidity and mortality in the immunocompromised host [1]. This disease can be localized, focally invasive or disseminated, when ...
5
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion
... undergoing allogeneic stem cell ...after allogeneic hematopoietic cell transplantation ...Marrow Transplantation (EBMT) ...
7
OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH ACTIVE DISEASE IN ACUTE MYELOID LEUKEMIA
... (3). Allogeneic stem cell transplantation (Allo-SCT) is not considered for the AML patients in good risk group in first com- plete remission, instead Allo-SCT should be conside- red in ...
5
Combined meta-analysis of systemic effects of allogeneic stem cell transplantation and systemic sclerosis
... Allogeneic stem cell transplantation (aSCT) has become a curative therapy for increasing numbers of ...after transplantation with median time to onset of 4–6 months ...
9
Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy
... abnormalities. Allogeneic stem cell transplantation is a therapeutic approach with known curative potential for patients with MDS that allows the achieve- ment of long-term disease ...
8
Development of leukemia in donor cells after allogeneic stem cell transplantation a survey of the European Group for Blood and Marrow Transplantation (EBMT)
... (donor cell leukemia; DCL) has been reported as a rare but severe complication of allogeneic stem cell transplantation ...Marrow Transplantation Group (EBMT) ...10489 ...
7
Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation
... Tam et al published updated results of a risk adapted strategy at the MD Anderson Cancer Center. Of a total of 121 patients enrolled in sequential transplant protocols over a 17 year study period, 86 underwent autoSCT. ...
10
Allogeneic stem cell transplantation for bone regeneration of a nonunion defect in a canine
... of allogeneic AT-MSCs implants did not produce adverse reactions in the ...of allogeneic MSCs based therapy of a natural clinical nonunion associated with ...
6
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
... Since the generation of adoptive T -cell therapy for each single virus in a separate manufacturing process is time- and cost-consuming, there are strong efforts to establish protocols for the generation of ...
10
Epstein-Barr virus-associated lymphoproliferative disease following allogeneic stem cell transplantation
... • Donor-derived ‘immunoblastic sarcomas’ in the early months following alloSCT reported in the late 1970s and early 1980s • 15 patients with a histological spectrum of EBV-associated. [r] ...
46
Individualized therapeutics in allogeneic stem cell transplantation
... lead to a more accurate measure of the predictive value of the two eQTLs, giving the possibility to study the effect of the eQTLs prospectively in pediatric patients with aGvHD. Furthermore, the physiological effect of ...
201
Role of autologous and allogeneic stem cell transplantation in myeloma.
... reliable allogeneic donor peripheral blood stem cell engraftment could be achieved with a very low dose of total body irradiation of 2 Gy and a combination of 2 potent immunosuppressive drugs ...
24
Implication of Early Lymphocyte Recovery after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Leukemia
... after allogeneic hematopoietic stem cell transplantation have an important role not only on the prevention of serious infec- tions in the early transplantation period, but also on the ...
9
Outcome of allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies.
... 41 allogeneic transplants were performed for hematological malignancies from April 2004 to December ...white cell recovery was 19±4 days (range:15-23 ...Conclusion: Allogeneic stem cell ...
9
Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation
... hematopietic stem cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor ...after allogeneic stem cell ...
6
Disseminated Aspergillosis Caused by Aspergillus ustusin a Patient Following Allogeneic Peripheral Stem Cell Transplantation
... marrow transplantation, in patients undergoing solid organ transplantation, or, rarely, in patients with acquired im- munodeficiency syndrome (1, 7, 14, 16, 20, 25, ...peripheral stem cell ...
5
Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
... monitoring MRD before and after transplantation may be helpful for clinicians to determine the best treatment options on a patient-by-patient basis. The prevention and treatment strategies for relapse of ALL after ...
8
Prediction of acute GVHD and relapse by metabolic biomarkers after allogeneic hematopoietic stem cell transplantation
... The main endpoints of this study were overall survival, disease-free survival, and relapse. The differen- tial variables were selected based on P value from the 2-tailed t test (P < 0.05), false discovery rate (FDR) ...
10